NCT01886690View on ClinicalTrials.gov

A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

August 20, 2013

Primary Completion Date

August 18, 2014

Study Completion Date

August 18, 2014

Conditions
Bilateral LASIK Surgery
Interventions
DRUG

carboxymethylcellulose sodium based new eye drop formulation

1 to 2 drops of carboxymethylcellulose sodium based New Eye Drop Formulation in each eye as per protocol for 90 days.

DRUG

carboxymethylcellulose sodium based eye drops

1 to 2 drops carboxymethylcellulose sodium based (REFRESH PLUS®) eye drops in each eye as per protocol for 90 days.

Trial Locations (2)

Unknown

New South Wales

Kelowna

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01886690 - A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery | Biotech Hunter | Biotech Hunter